Page last updated: 2024-09-02

ci 988 and methadone

ci 988 has been researched along with methadone in 2 studies

Compound Research Comparison

Studies
(ci 988)
Trials
(ci 988)
Recent Studies (post-2010)
(ci 988)
Studies
(methadone)
Trials
(methadone)
Recent Studies (post-2010) (methadone)
14781413,6301,4633,957

Protein Interaction Comparison

ProteinTaxonomyci 988 (IC50)methadone (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)7.5
Mu-type opioid receptorHomo sapiens (human)0.0041
Delta-type opioid receptorHomo sapiens (human)1.09
Kappa-type opioid receptorHomo sapiens (human)0.512
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)9.7724

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FourniƩ-Zaluski, MC; Maldonado, R; Roques, BP; Ruiz, F1
Canestrelli, C; Chen, H; Cupo, A; FourniƩ-Zaluski, MC; Le Guen, S; Maldonado, R; Mas Nieto, M; Noble, F; Roques, BP1

Other Studies

2 other study(ies) available for ci 988 and methadone

ArticleYear
Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.
    British journal of pharmacology, 1996, Volume: 119, Issue:1

    Topics: Analgesics; Animals; Disulfides; Drug Combinations; Enkephalins; Indoles; Male; Meglumine; Methadone; Morphine; Naloxone; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substance Withdrawal Syndrome

1996
Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone.
    Pain, 2003, Volume: 104, Issue:1-2

    Topics: Aminopeptidases; Analgesics; Animals; Disease Management; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Indoles; Male; Meglumine; Methadone; Mice; Pain; Pain Measurement; Prodrugs; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin

2003